Effect of aprotinin on fibrinopurulent peritonitis in rats.
The effect of aprotinin on the clinical and pathologic course of experimentally induced peritonitis in the rat was studied. Peritonitis was induced in 40 rats by creating a closed ileal loop 4 cm long 5 cm from the ileocecal valve. The rats were divided into two groups of 20 rats each. Group 1 served as a control group, whereas each animal in Group 2 received a bolus dose of aprotinin (10 ml) intraperitoneally immediately after closing the laparotomy. In the aprotinin-treated group, survival was drastically increased (p less than 0.01) and formation of adhesions and abscesses was considerably reduced. The results of peritoneal cultures showed a decreased incidence of Escherichia coli and Clostridia in the aprotinin-treated group. We conclude that the administration of aprotinin significantly prolongs the survival time of animals with peritonitis and reduces the development of adhesions and abscesses in the peritoneal cavity. This beneficial effect can be attributed to decreased fibrinogen deposits within the peritoneal cavity and the stabilization of the organism after bacterial shock. Thus, bacteria were more susceptible to cellular and noncellular clearing mechanisms.
G E
GE
Chalkiadakis
A
A
Kostakis
P
P
Karydakis
M E
ME
Chalkiadakis
P
P
Matsikas
P E
PE
Karayannoccos
M
M
Sechas
G D
GD
Skalkeas
D000038:Abscess / Q000503:physiopathology / Q000517:prevention & control*; D000818:Animals; D007611:Aprotinin / Q000494:pharmacology*; D003015:Clostridium Infections / Q000503:physiopathology / Q000517:prevention & control; D004927:Escherichia coli Infections / Q000503:physiopathology / Q000517:prevention & control; D005260:Female; D005337:Fibrin / Q000502:physiology*; D008297:Male; D010538:Peritonitis / Q000401:mortality / Q000503:physiopathology / Q000517:prevention & control*; D051381:Rats; D011919:Rats, Inbred Strains; D013530:Surgical Wound Infection / Q000503:physiopathology / Q000517:prevention & control; D000267:Tissue Adhesions / Q000503:physiopathology / Q000517:prevention & control
D005337:Fibrin; D007611:Aprotinin